Anticoagulation management for cardiopulmonary bypass using TEG® 6 s in a patient receiving both heparin and dabigatran

TEG could help physicians to determine need for idarucizumab and also an adequate dose of heparin to establish appropriate anticoagulation for CPB.

Authors

Institutions

Publication Details

Journal
JA Clinical Reports
Published
2024-09-04
DOI
https://doi.org/10.1186/s40981-024-00739-8
Primary Topic
Venous Thromboembolism Diagnosis and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Anticoagulation management for cardiopulmonary bypass using TEG® 6 s in a patient receiving both heparin and dabigatran

Nobuyuki Katori, Keiko Kaji, Yu Kawada, Shoko Fujioka et al.
JA Clinical Reports
Venous Thromboembolism Diagnosis and Management
article

Anticoagulation management for cardiopulmonary bypass using TEG® 6 s in a patient receiving both heparin and dabigatran

Nobuyuki Katori, Keiko Kaji, Yu Kawada, Shoko Fujioka, Tomoki Yamaguchi
article en

Abstract

TEG could help physicians to determine need for idarucizumab and also an adequate dose of heparin to establish appropriate anticoagulation for CPB.

JA Clinical ReportsVol. 10(1)
Jikei University School of Medicine (JP)
Good health and well-being
Openalex Percentile: Top 71%
Venous Thromboembolism Diagnosis and Management
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.